Cargando…
Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer’s Disease Brain
Molecular changes in the brain of individuals afflicted with Alzheimer's disease (AD) are an intense area of study. Little is known about the role of protein abundance and posttranslational modifications in AD progression and treatment, in particular large-scale intact N-linked glycoproteomics...
Autores principales: | Suttapitugsakul, Suttipong, Stavenhagen, Kathrin, Donskaya, Sofia, Bennett, David A., Mealer, Robert G., Seyfried, Nicholas T., Cummings, Richard D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706167/ https://www.ncbi.nlm.nih.gov/pubmed/36309312 http://dx.doi.org/10.1016/j.mcpro.2022.100433 |
Ejemplares similares
-
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
por: Higginbotham, Lenora, et al.
Publicado: (2020) -
Unraveling the surface glycoprotein interaction network by integrating chemical crosslinking with MS-based proteomics
por: Sun, Fangxu, et al.
Publicado: (2021) -
Spatial and temporal proteomics reveals the distinct distributions and dynamics of O-GlcNAcylated proteins
por: Xu, Senhan, et al.
Publicado: (2022) -
Systematic analysis of the impact of phosphorylation and O-GlcNAcylation on protein subcellular localization
por: Xu, Senhan, et al.
Publicado: (2023) -
Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s disease
por: Zhang, Qi, et al.
Publicado: (2020)